Intramural Hematoma Clinical Trials

6 recruitingLast updated: July 25, 2026

There are 6 actively recruiting intramural hematoma clinical trials across 11 countries. Studies span Not Applicable. Top locations include Chapel Hill, North Carolina, United States, Durham, North Carolina, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Intramural Hematoma Trials at a Glance

6 actively recruiting trials for intramural hematoma are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Chapel Hill, Durham, and Baltimore. Lead sponsors running intramural hematoma studies include Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd, Endospan Ltd., and Rodney A. White, MD.

Browse intramural hematoma trials by phase

Treatments under study

About Intramural Hematoma Clinical Trials

Looking for clinical trials for Intramural Hematoma? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intramural Hematoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intramural Hematoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

Aneurysm of Aorta, ThoracicDissection of Thoracic AortaDissection of Thoracic Descending Aorta+3 more
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd100 enrolled4 locationsNCT07668687
Recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Aneurysm ThoracicVascular DiseaseDissection+5 more
W.L.Gore & Associates1,500 enrolled36 locationsNCT06658730
Recruiting
Not Applicable

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Aortic AneurysmAortic DissectionIntramural Hematoma+1 more
Endospan Ltd.110 enrolled32 locationsNCT04471909
Recruiting
Not Applicable

Feasibility of Endovascular Repair Of Ascending Aortic Pathologies

Aortic DissectionPseudoaneurysmIntramural Hematoma+1 more
Rodney A. White, MD20 enrolled3 locationsNCT02201589
Recruiting
Not Applicable

CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions

Intramural HematomaPenetrating Aortic UlcerAortic Dissection Type B
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd130 enrolled1 locationNCT05874206
Recruiting

ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"

Cardiovascular DiseasesThoracic Aortic AneurysmVascular Diseases+5 more
Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery100 enrolled1 locationNCT05309707